Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DG31WX
|
|||
| Drug Name |
ALLN-346
|
|||
| Drug Type |
Enzyme replacement
|
|||
| Indication | Chronic kidney disease [ICD-11: GB61; ICD-10: N18, N18.9] | Phase 2 | [1] | |
| Gout [ICD-11: FA25; ICD-10: M10] | Phase 2 | [2] | ||
| Company |
Allena Pharmaceuticals Newton, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04987294) A Randomized, Double-Blind, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects With Gout and Mild to Moderate Chronic Kidney Disease. U.S.National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT04987242) An Inpatient, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.